Accession Number: | 0001209191-21-052580 |
Date: | 2021-08-18 |
Issuer: | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) |
Original Submission Date: |
HANHAM ANN
C/O HTG MOLECULAR DIAGNOSTICS, INC.
3430 E. GLOBAL LOOP
TUCSON, AZ 85706
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.25 | 2021-08-18 | deemed execution date | A | 4,000 (a) | 2031-08-17 | common stock 4,000 | $6.25 | 4,000 | direct |
ID | footnote |
---|---|
f1 | the shares will vest on the earlier of august 18, 2022 or the date of the next annual meeting of stockholders. |